{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-024714","form_type":"8-K","ticker":"SSKN","cik":"0001051514","company_name":"STRATA Skin Sciences, Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.781921+00:00","generated_at":"2026-06-15T00:29:45.024802+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"STRATA Skin Sciences Q1 revenue up 8.6% to $7.6M; net loss widens to $2.8M","bullets":["Revenue of $7.6M vs $7.0M YoY; global recurring revenue $5.2M, equipment revenue $2.4M.","Net loss of $2.8M ($0.08 loss per share) vs net loss of $2.5M ($0.07 per share) YoY.","Launched TheraClear X in Jan 2023; placed 44 devices in Q1, total 58 U.S. placements.","Sold over 3,000 TheraClear treatments in Q1; signed India distribution deal with Spectra Medical.","Full-year 2023 revenue guidance reaffirmed at $38M–$40M."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-024714","json":"https://secwatch.observer/filing/0001140361-23-024714.json","markdown":"https://secwatch.observer/filing/0001140361-23-024714.md","text":"https://secwatch.observer/filing/0001140361-23-024714.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1051514/000114036123024714/0001140361-23-024714-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1051514/000114036123024714/brhc20052965_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:29:45.024802+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"afdde8c021b080215e76a59611df1da414c4a7d9","claim":"STRATA Skin Sciences, Inc. reported first quarter ended March 31, 2023 results: revenue $7.6 million, net income $2.8 million, EPS loss of $0.08 per basic and diluted common share. Guidance reaffirmed.","evidence_excerpt":"EXHIBIT 99.1 Exhibit 99.1 Press Release dated May 15, 2023 issued by STRATA Skin Sciences, Inc. STRATA Skin Sciences Reports First Quarter 2023 Revenue Achieved revenue of $7.6 million for the first quarter 2023 Company to host conference call and webcast today, May 15, 2023, at 4:30 PM ET HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1051514/000114036123024714/0001140361-23-024714-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$7.6 million"},{"label":"Net income","value":"$2.8 million"},{"label":"EPS","value":"loss of $0.08 per basic and diluted common share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}